Alexander Denner, senior managing director of Icahn Partners LP (IEP) and a leading player in health care investments by firm founder Carl Icahn, is considering leaving to start his own hedge fund, Bloomberg News reported Thursday, citing two people with knowledge of the plan.
Denner, 42 years old, would open his fund firm by the end of this year, and Icahn might invest in it, one of the sources told Bloomberg.
Icahn wasn't available to comment, the news service cited an assistant to the famed activist investor as saying.
Since joining Icahn's New York firm in 2006, Denner has been instrumental in management shuffles, efforts to boost sales or restructurings of at least six pharmaceutical companies. He is chairman of Enzon Pharmaceuticals Inc. (ENZN) and serves on the boards of Biogen Idec Inc. (BIIB) and Amylin Pharmaceuticals Inc. (AMLN).
An Icahn team led by Denner failed in August to win representation on Forest Laboratories Inc.'s (FRX) board after the drugmaker proposed three new directors of its own.
Full story at http://www.bloomberg.com/news/2011-09-15/icahn-s-denner-said-to-consider-leaving-to-start-own-hedge-fund.html
-Dow Jones Newswires; 212-416-2900